# BIODEXA PHARMACEUTICALS PLC (BDRXXXXX)

> Institutional ownership reported to the SEC as of Q2 2023, from Form 13F filings. Source: https://holderbook.com/stocks/BDRXXXXX/

- Reporting holders: 8
- Reported value: $45.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Cubist Systematic Strategies, LLC](https://holderbook.com/funds/1603465-cubist-systematic-strategies-llc/) | $18.2K | 265,993 | 0.0% | 1 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $14.0K | 204,300 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $9.8K | 142,208 | 0.0% | 1 |
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $2.6K | 37,865 | 0.0% | 1 |
| [Baader Bank Aktiengesellschaft](https://holderbook.com/funds/1542629-baader-bank-aktiengesellschaft/) | $865 | 16,250 | 0.0% | 1 |
| [RHUMBLINE ADVISERS](https://holderbook.com/funds/1115418-rhumbline-advisers/) | $163 | 2,370 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $94 | 1,368 | 0.0% | 2 |
| [Federation des caisses Desjardins du Quebec](https://holderbook.com/funds/2022297-federation-des-caisses-desjardins-du-quebec/) | $12 | 180 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2023 | 8 | $45.8K |
| Q1 2023 | 7 | $72.0K |

